All news articles for August 2023

© Getty Images

Danaher acquires Abcam shares in deal worth $5.7BN

By Liza Laws

Danaher is to acquire Abcam for $24 per share - a total enterprise value of approximately $5.7 billion representing approximately 40% more than Abcam's undisclosed share prices in May.

© Getty Images

Further investment for BDD Pharma after £2M funding round

By Liza Laws

Integrated drug formulation and clinical trials company, BDD Pharma, will be expanding its phase appropriate development, manufacturing, and clinical testing services after a £2 million ($1.3 million) investment.

© Getty Images

New appointments: Who are the movers and shakers in pharma?

By Isabel Cameron

BioPharma Reporter and Outsourcing Pharma presents its latest round-up of the movers and shakers in the pharma industry. From Karuna Therapeutics to IO Biotech, we break down the key changes on the pharmaceutical job ladder.

Follow us


View more